HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Experimental study on the effects of sclerosants for esophageal varices on blood coagulation, fibrinolysis and systemic hemodynamics.

Abstract
The effects of five sclerosants used for treating esophageal varices on blood coagulation and fibrinolysis, systemic hemodynamics, and vascular endothelial cells were studied in mongrel dogs. With each sclerosant, hemolysis and a decrease in the platelet count were observed. Changes in the blood coagulation system occurred immediately after sclerosant administration. Prolongation of the PT and APTT and decreases in fibrinogen and alpha 2-PI were seen in the thrombin (TH), sodium tetradecyl sulfate (STS), and ethanolamine oleate (EO) groups. Polidocanol (PO) and absolute ethanol (ET) had less pronounced effects on these systems. A transient decrease in the cardiac index (CI), pulmonary artery pressure (PAP) and pulmonary artery resistance (PAR) was observed with the administration of the sclerosants, especially in the TH and STS groups. Excessive vascular endothelial damage was observed in the ET group, marked damage was seen in the EO and STS groups and slight damage was recorded in the PO and TH groups.
AuthorsN Suzuki, A Nakao, T Nonami, H Takagi
JournalGastroenterologia Japonica (Gastroenterol Jpn) Vol. 27 Issue 3 Pg. 309-16 (Jun 1992) ISSN: 0435-1339 [Print] Japan
PMID1624075 (Publication Type: Journal Article)
Chemical References
  • Oleic Acids
  • Sclerosing Solutions
  • Polidocanol
  • Polyethylene Glycols
  • Thrombin
  • Sodium Tetradecyl Sulfate
  • ethanolamine oleate
Topics
  • Animals
  • Blood Coagulation (drug effects)
  • Dogs
  • Endothelium, Vascular (pathology)
  • Esophageal and Gastric Varices
  • Fibrinolysis (drug effects)
  • Hemodynamics (drug effects)
  • Oleic Acids (pharmacology)
  • Platelet Count (drug effects)
  • Polidocanol
  • Polyethylene Glycols (pharmacology)
  • Sclerosing Solutions (pharmacology)
  • Sodium Tetradecyl Sulfate (pharmacology)
  • Thrombin (pharmacology)
  • Thrombophlebitis (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: